MIRA 2026 - Microrobotics for real-world medical applications

Welcome to MIRA 2026 - Microrobotics for Real-World Medical Applications international conference

Medical microrobotics is uniquely appealing because it enables minimally invasive interventions, precise targeted delivery of therapeutics, enhanced imaging and diagnostics, and access to previously unreachable tissues or organs. These capabilities offer transformative opportunities to improve patient outcomes, reduce procedure-related risks, and redefine standard clinical care.

Building on these potential applications, this conference will bring together researchers, engineers, clinicians, and industry experts to explore the cutting-edge field of medical microrobotics and its translation into clinical practice. By fostering interdisciplinary dialogue among medical doctors, materials scientists, bioengineers, and specialists in micro- and nanobiotechnologies, the event aims to identify pressing medical challenges and showcase how robotic and cell-based microrobotic systems can provide innovative solutions.

The conference will also highlight the field’s evolution from in vitro studies to preclinical animal models, illustrating how technological advances have paved the way for early translational applications and the emergence of spin-off companies. These enterprises are actively working to secure the resources needed to advance toward first-in-human trials, underscoring the growing real-world impact of medical microrobotics.

Through invited lectures, panel discussions, and interactive sessions, participants will gain a comprehensive understanding of the scientific, technological, and clinical landscape, while building collaborations that bridge basic research, engineering, and patient-centered care. The event is designed to inspire innovation, promote translational research, and accelerate the adoption of microrobotic solutions that address critical medical needs.

Key topics include:

• Translational Pathways: from in vitro studies to preclinical models, highlighting lessons from current clinical implementation of advanced therapies (gene editing, stem cells, immunotherapies).   

• Technological Innovations: Advances in micro- and nanorobotics for medical interventions, diagnostics, and therapeutic delivery.

• Unique Functionalities of Medical Microrobotics: Advantages over existing delivery systems, particularly for life-threatening diseases or niche medical cases.

• Regulatory and Ethical Considerations: Challenges and strategies for first-in-human trials and clinical translation.

• Entrepreneurship and Commercialization: Emerging spin-offs, funding strategies, and pathways to market adoption.

• Collaborative Opportunities: Strengthening partnerships among academia, industry, and clinical stakeholders to accelerate innovation.

The conference will emphasize interactive discussions to connect technological development with actual clinical needs, ensuring that research efforts are aligned with patient-centric solutions.